Local treatment for rectal cancer
- PMID: 20011199
- PMCID: PMC2789514
- DOI: 10.1055/s-2007-984862
Local treatment for rectal cancer
Abstract
The treatment of rectal cancer includes both radical resection and local therapy. Radical resection remains the standard treatment, but is associated with increased morbidity and mortality, as well as the potential need for a temporary and occasionally, a permanent ostomy. The benefits of local treatment include a less invasive procedure with maintenance of bowel function and avoidance of a stoma. However, the efficacy of local treatment is now being challenged as the rates of recurrence after local excision alone appear to be much higher than previously thought. Although the primary goal of an oncologic resection is disease eradication, each case must be individualized to determine an optimal care plan.
Keywords: Rectal cancer; chemotherapy; local excision; radiation therapy; recurrence; transanal endoscopic microsurgery.
Similar articles
-
Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond.J Gastrointest Oncol. 2015 Jun;6(3):296-306. doi: 10.3978/j.issn.2078-6891.2015.022. J Gastrointest Oncol. 2015. PMID: 26029457 Free PMC article. Review.
-
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.Dis Colon Rectum. 2013 Jan;56(1):6-13. doi: 10.1097/DCR.0b013e318273f56f. Dis Colon Rectum. 2013. PMID: 23222274
-
Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer.Dis Colon Rectum. 2012 Mar;55(3):262-9. doi: 10.1097/DCR.0b013e318241ef22. Dis Colon Rectum. 2012. PMID: 22469792
-
Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2-T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME).Int J Colorectal Dis. 2018 Feb;33(2):241-249. doi: 10.1007/s00384-017-2942-1. Epub 2017 Dec 12. Int J Colorectal Dis. 2018. PMID: 29234923 Clinical Trial.
-
Controversies in the management of early rectal cancer.Minerva Chir. 2015 Dec;70(6):467-80. Epub 2015 Sep 16. Minerva Chir. 2015. PMID: 26375899 Review.
Cited by
-
The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes In Rectal Cancer.Curr Colorectal Cancer Rep. 2017 Feb;13(1):61-72. doi: 10.1007/s11888-017-0351-z. Epub 2017 Mar 10. Curr Colorectal Cancer Rep. 2017. PMID: 29445322 Free PMC article.
-
The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer.J Med Life. 2017 Jan-Mar;10(1):99-103. J Med Life. 2017. PMID: 28255388 Free PMC article.
-
Oncological outcomes of transanal local excision for high risk T(1) rectal cancers.World J Gastrointest Oncol. 2012 Apr 15;4(4):84-8. doi: 10.4251/wjgo.v4.i4.84. World J Gastrointest Oncol. 2012. PMID: 22532882 Free PMC article.
-
Ablative therapies for colorectal polyps and malignancy.Biomed Res Int. 2014;2014:986352. doi: 10.1155/2014/986352. Epub 2014 Jun 26. Biomed Res Int. 2014. PMID: 25089281 Free PMC article. Review.
References
-
- Lisfranc J. Observation sur une affection cancereuse du rectume guerie par l'excision. Rev Med Franc Etrang. 1826;2:380–382.
-
- Czerny V. Casuistische mittheilugen aus der chirurg Klin zu Heidelberg. Munch Med Wchnschr. 1894:11–14.
-
- Miles W E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet. 1908;ii:1812–1813. - PubMed
-
- Lavery I C, Lopez-Kostner F, Fazio V W, et al. Chances of cure are not compromised with sphincter-saving procedures for cancers of the lower third of the rectum. Surgery. 1997;122(4):779–784. - PubMed